Picture of HALEON logo

HLN HALEON News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG - Haleon PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250502:nRSB2926Ha&default-theme=true

RNS Number : 2926H  Haleon PLC  02 May 2025

 

Haleon plc: Director/PDMR Shareholding

 

2 May 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").

 

On 2 May 2025, the Company received notification of the following transaction
as detailed below.

 

 1       Details of the person discharging managerial responsibilities / person closely

       associated

 a)      Name                                                             Asmita Dubey

 2       Reason for the notification

 a)      Position/status                                                  Independent Non-Executive Director - PDMR

 b)      Initial notification /Amendment                                  Initial Notification

 3       Details of the issuer, emission allowance market participant, auction

       platform, auctioneer or auction monitor

 a)      Name                                                             Haleon plc

 b)      LEI                                                              549300PSB3WWEODCUP19

 4       Details of the transaction(s): section to be repeated for (i) each type of

       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
         place where transactions have been conducted

 a)      Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

         Identification code                                              GB00BMX86B70

 b)      Nature of the transaction                                        Purchase of Ordinary Shares in the Company 

 c)      Price(s) and volume(s)

                                                                                            Price(s)          Volume(s)
                                                                                            £4.01             15,424

 d)      Aggregated information                                            N/A - single transaction

         - Aggregated volume

         - Price

 e)      Date of the transaction                                          2 May 2025

 f)      Place of the transaction                                         London Stock Exchange (XLON)

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBDGDUDUGDGUD

Recent news on HALEON

See all news